Related Experiment Video
Updated: Jul 11, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Impact of the COVID-19 Pandemic on Infective Endocarditis Management and Outcomes: Analysis of a National Clinical
Alexandra Novelli1, Arnar B Ingason2, Caroline Jirka2
1Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Insights
The COVID-19 pandemic worsened outcomes for general infective endocarditis (IE) admissions but improved mortality for valve surgery patients. This study analyzed national IE trends before and after the pandemic declaration, revealing significant shifts in patient complexity and survival rates.
Area of Science:
- Cardiology and Infectious Diseases
- Healthcare Management and Outcomes Research
- Epidemiology of Cardiovascular Infections
Background:
- The COVID-19 pandemic significantly disrupted healthcare delivery globally.
- The specific impact of the pandemic on infective endocarditis (IE) management and outcomes, particularly valve surgery, remained unclear.
- Understanding these shifts is crucial for optimizing patient care during public health crises.
Purpose of the Study:
- To compare national trends in infective endocarditis (IE) admissions, patient demographics, and clinical outcomes before and after the onset of the COVID-19 pandemic.
- To evaluate the impact of the pandemic on patients undergoing valve surgery for IE.
- To identify changes in IE patient complexity and associated mortality rates.
Main Methods:
- Utilized a national sample of IE admissions from the Vizient Clinical Database (2016-2022).
- Defined pre-COVID-19 and post-COVID-19 periods based on the pandemic declaration in Q2 2020.
- Employed 2-sample t tests, chi-square tests, and propensity score-matched analyses to compare baseline characteristics and outcomes between the two periods for all IE admissions and those involving valve surgery.
Main Results:
- Post-pandemic IE admissions showed increased in-hospital mortality (11.4% vs 12.4%), stroke (4.9% vs 6.0%), myocardial infarction (1.3% vs 1.4%), and aspiration pneumonia (1.8% vs 2.4%) in the matched analysis.
- Patients undergoing valve surgery during the pandemic experienced decreased in-hospital mortality (7.7% vs 6.7%) and shorter intensive care unit stays (8.5 vs 8.0 days) in the matched analysis.
- Overall IE admissions decreased significantly post-pandemic (82,867 to 45,672) as did valve surgery admissions (11,337 to 6,322).
Conclusions:
- Patients admitted with infective endocarditis after the COVID-19 onset were more medically complex, exhibiting worsened outcomes and higher mortality.
- Conversely, patients undergoing valve surgery for IE demonstrated improved mortality and stable outcomes despite the pandemic's challenges.
- These findings highlight a divergence in pandemic impact based on IE management strategy, emphasizing the resilience of surgical interventions.
Abstract:
COVID-19 has widely affected health care delivery, but its impact on the management of infective endocarditis (IE), including valve surgery, is uncertain. We compared the national trends in admissions, demographics, and outcomes of IE before and after COVID-19 onset, using a national sample of IE admissions between 2016 and 2022 from the Vizient Clinical Database. The pre-COVID-19 and post-COVID-19 time periods were separated by the start of the second quarter of 2020, the time during which the COVID-19 pandemic was declared. For all admissions and for admissions involving valve surgery, pre-COVID-19 versus post-COVID-19 baseline characteristics and outcomes were compared using 2-sample t tests or chi-square tests. Propensity score-matched cohorts were similarly compared. Before COVID-19, there were 82,867 overall and 11,337 valve-related surgical admissions, and after COVID-19, there were 45,672 overall and 6,322 valve-related surgical admissions. In the matched analysis for all admissions, the in-hospital mortality increased from 11.4% to 12.4% after COVID-19 onset (p <0.001); in-hospital stroke (4.9% vs 6.0%, p <0.001), myocardial infarction (1.3% vs 1.4%, p = 0.03), and aspiration pneumonia (1.8% vs 2.4%, p <0.001) also increased, whereas other complications remained stable. In the matched analysis of surgical admissions, there was decreased in-hospital mortality (7.7% vs 6.7%, p = 0.03) and intensive care unit stay (8.5 ± 12.5 vs 8.0 ± 12.6 days, p = 0.04); other outcomes remained stable. In conclusion, patients admitted with IE after COVID-19 were more medically complex with worsened outcomes and mortality, whereas patients who underwent valve surgery had stable outcomes and improved mortality despite the pandemic.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management

